LyGenesis and Imagine Pharma to jointly develop cell therapies for Patients with Type 1 diabetes
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Natco launched pomalidomide under their brand NAT-POMALIDOMIDE in strengths of 1 mg, 2 mg, 3 mg and 4 mg capsules
Twelve hospitals across India will be part of the network which will support the trial in India
New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator
Subscribe To Our Newsletter & Stay Updated